These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 8513459

  • 1. Controlling the costs of antibiotic resistance.
    North D.
    Clin Ther; 1993; 15 Suppl A():3-11. PubMed ID: 8513459
    [Abstract] [Full Text] [Related]

  • 2. Antibiotic cost control measures in a hospital pharmacy.
    Manzo J, Amodio-Groton MA, Kleinmann K.
    Clin Ther; 1993; 15 Suppl A():37-43. PubMed ID: 8513460
    [Abstract] [Full Text] [Related]

  • 3. Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics committee restrictions.
    Hayman JN, Sbravati EC.
    Am J Hosp Pharm; 1985 Jun; 42(6):1343-7. PubMed ID: 4014250
    [Abstract] [Full Text] [Related]

  • 4. Development and implementation of a comprehensive, criteria-based drug-use review program.
    Todd MW, Keith TD, Foster MT.
    Am J Hosp Pharm; 1987 Mar; 44(3):529-35. PubMed ID: 3471089
    [Abstract] [Full Text] [Related]

  • 5. Effect of antibiotic order form guiding rational use of expensive drugs on cost containment.
    Sirinavin S, Suvanakoot P, Sathapatayavongs B, Malatham K.
    Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):636-42. PubMed ID: 10437971
    [Abstract] [Full Text] [Related]

  • 6. Antibiotic restriction in hospitals associated with medical schools.
    Klapp DL, Ramphal R.
    Am J Hosp Pharm; 1983 Nov; 40(11):1957-60. PubMed ID: 6650526
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Methods of controlling cephalosporin use in Canadian hospitals.
    Godin JP, Sketris IS, Merrett RA, Marrie TJ.
    Can J Hosp Pharm; 1988 Apr; 41(2):73-4, 83-4, 96. PubMed ID: 10287052
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Controlling financial variables--changing prescribing patterns.
    Abramowitz PW.
    Am J Hosp Pharm; 1984 Mar; 41(3):503-15. PubMed ID: 6367444
    [Abstract] [Full Text] [Related]

  • 15. Antimicrobial formulary management: meeting the challenge in a health maintenance organization.
    Carlson JA.
    Pharmacotherapy; 1991 Mar; 11(1 ( Pt 2)):32S-35S. PubMed ID: 2011571
    [Abstract] [Full Text] [Related]

  • 16. Assuring rational antibiotic use: the impact of a joint microbiology-pharmacy surveillance program.
    Plumridge RJ, McGechie DB.
    Aust Health Rev; 1984 Mar; 7(4):269-77. PubMed ID: 10269945
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Control of antibiotic-resistant bacteria: memorandum from a WHO meeting. World Health Organization Scientific Working Group on Antimicrobial Resistance.
    Am J Hosp Pharm; 1984 Jul; 41(7):1329-37. PubMed ID: 6540519
    [Abstract] [Full Text] [Related]

  • 20. Third generation cephalosporin use in a tertiary hospital in Port of Spain, Trinidad: need for an antibiotic policy.
    Pinto Pereira LM, Phillips M, Ramlal H, Teemul K, Prabhakar P.
    BMC Infect Dis; 2004 Dec 15; 4(1):59. PubMed ID: 15601475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.